MOESM5 of Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

Additional file 5: Fig. S1. Impact of UGT1A1*28 or *6 on event-free survival (EFS) in AML patients. (a, d) comparison of EFS among genotypes of UGT1A1*28. (b, e) comparison of among genotypes of UGT1A1*6. (c, f) combined effects of UGT1A1*28 and *6 on EFS. Fig. S2. Flow chart of the study population. Fig. S3. Gene expression of CDA and UGT1A1 mRNA in blasts from AML patients from the Cancer Genome Atlas (TCGA) dataset (n = 173). AML blast cells scarcely express UGT1A1

MOESM2 of Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)

Additional file 2: Table S2. Multivariate Cox regression analysis of clinical factors influencing AML OS and RFS

MOESM1 of Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

Additional file 1: Table S1. Primer sequences used to genotype UGT1A1*28 and *6

MOESM3 of Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

Additional file 3: Table S3. Comparison of CR rate among UGT1A1 genotypes after the first course of induction therapy

MOESM4 of Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens

Additional file 4: Table S4. Comparison of TRM among UGT1A1 genotypes after two cycles of induction therapy in AML patients

MOESM1 of Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML)

Additional file 1: Table S1. Unconditional logistic regression analysis of clinical variables associated with non-CR risk in AML patients

Additional file 1 of “None of us are lying”: an interpretive description of the search for legitimacy and the journey to access quality health services by individuals living with Long COVID

Additional file 1: Appendix A. Participant self-identified cultural or ethic background